SSM Cardinal Glennon Children's Medical Center
BiotechSSM Cardinal Glennon Children's Medical Center is a biotechnology company with 1 FDA-approved products.
SSM Cardinal Glennon Children's Medical Center's Key Drugs
SSM Cardinal Glennon Children's Medical Center's core commercial portfolio centers on Allocord — its most strategically important drugs approved in the last 15 years.
SSM Cardinal Glennon Children's Medical Center's Recent FDA Approvals
New NDA/BLA approvals for SSM Cardinal Glennon Children's Medical Center over the last two years — novel drugs only, excluding generics and label supplements.
SSM Cardinal Glennon Children's Medical Center's Therapeutic Areas
Disease areas where SSM Cardinal Glennon Children's Medical Center has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SSM Cardinal Glennon Children's Medical Center Pipeline Snapshot
Active clinical trials for SSM Cardinal Glennon Children's Medical Center across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Allocord leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2013-05-29
- Latest
- 2013-05-29
- Applications
- 1